Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis

CONCLUSIONS: There is great variability in ILD prevalence among patients with COVID-19 across the globe. Pre-existing ILD is associated with higher severity and mortality of COVID-19.PMID:34547678 | PMC:PMC8450148 | DOI:10.1016/j.intimp.2021.108145
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research